Alliance in Action

The NCI Alliance for Nanotechnology in Cancer is catalyzing targeted discovery and development efforts that offer the greatest advances in the near and medium terms and to lower the barriers for those advances to be handed off to the private sector for commercial development. The Alliance focuses on translational research and development work in the following six major challenge areas, where nanotechnology can have the biggest and fastest impact:

Molecular Imaging and Early Detection
In Vivo Nanotechnology Imaging Systems
Reporters of Efficacy
Multifunctional Therapeutics
Prevention and Control
Research Enablers

The Alliance's programs foster innovation and collaboration among researchers within and between institutions, as well as across scientific disciplines. Through these varied and dynamic programs, the Alliance is providing opportunities for individuals and organizations to participate and contribute to research that uses nanotechnology to improve clinical outcomes for cancer patients.

Alliance Programs

Learn more about each of the Alliance programs »

Recent Accomplishments
Alliance program accomplishments have resulted in a significant flow of publications in the scientific literature and products approaching human clinical trials. Read detailed information on the Alliance members' accomplishments »

Meetings and Events
By engaging with researchers in different disciplines, Alliance members are able to share their advances in cancer research and identify new and diverse partners for future collaborations. See where Alliance members are participating in upcoming meetings and events »

News and Highlights
Stay up to date on what is new within the Alliance and in the field of nanotechnology. Read the latest Alliance news coverage »

Published Research
Access articles published in the scientific literature related to nanotechnology and advances in cancer research and care. View Alliance published research »